2 results match your criteria: "Isahaya Ryoiku Center[Affiliation]"

Gastroesophageal reflux (GER) is a common episode in pediatric patients with severe motor and intellectual disabilities (SMID) and occasionally leads to a severe clinical state accompanied with nausea, hematemesis, melena, wheezing, pneumonia, anemia and/or failure to thrive. We report here a case of a 14-year-old male with Lennox syndrome who had been treated with a histamine H2 blocker intravenously or via a nasogastric tube for repeated gastric hemorrhage due to severe GER. Since his gastric hemorrhage became resistant to the H2 blocker, we decided to replace it with a proton pump inhibitor (PPI).

View Article and Find Full Text PDF
Article Synopsis
  • Phenytoin (PHT) has nonlinear pharmacokinetics, meaning small dose changes can significantly impact serum levels.
  • Although the main formulations (tablets, 97% fine granules, and 10% powder) are considered bioequivalent, changes in formulation can lead to notable increases in serum PHT levels.
  • A study showed that switching from 97% fine granules to 10% powder resulted in a 16% higher serum concentration-to-dose ratio, indicating potential risks of PHT toxicity with such formulation changes.
View Article and Find Full Text PDF